"Post-diagnosis physical activity is associated with a significant reduction in mortality among breast cancer patients, most notably in women aged 55 and older. Empirical evidence underscores the critical role of an active lifestyle in improving long-term clinical outcomes 12."
"Breast masses may be incidentally identified on CT, but CT is not the preferred modality for dedicated breast evaluation and is primarily used to assess metastatic disease11. If calcifications are visualised on CT, they are nearly all benign 9."
"BRCA1 or BRCA2 mutation"
"human epidermal growth factor receptor 2 (HER2), also known as proto-oncogene Neu or receptor tyrosine-protein kinase erbB-2"
"oestrogen receptor (ER)"
"Staging of breast tumours is performed according to the TNM system published by the American Joint Committee on Cancer (AJCC) / Union for International Cancer Control (UICC): breast cancer (staging)."
"Staging of breast tumours is performed according to the TNM system published by the American Joint Committee on Cancer (AJCC) / Union for International Cancer Control (UICC): breast cancer (staging)."
"Staging of breast tumours is performed according to the TNM system published by the American Joint Committee on Cancer (AJCC) / Union for International Cancer Control (UICC): breast cancer (staging)."
"The use of a standard lexicon is recommended to enhance communication with referrers and audit performance: breast imaging-reporting and data system (BI-RADS)."
"Beyond these routine markers, recent genome-wide association studies (GWAS) have significantly refined our understanding of the disease's aetiology. Research has demonstrated that genetic susceptibility to breast cancer is characterised by marked subtype-specific heterogeneity. Rather than conferring a uniform risk, most common susceptibility loci differentially modulate the onset of specific molecular phenotypes (e.g., luminal vs. triple-negative). This suggests that an individual's unique genomic profile does more than just quantify overall oncological risk; it directly shapes the biological identity and dictates the clinical trajectory of the neoplasm 13."
Expected headings
"Protective factors"
"Staging"
"Radiographic appearance"
"Mammography"
"Ultrasound"
"MRI"
"CT"
"Beyond these routine markers, recent genome-wide association studies (GWAS) have significantly refined our understanding of the disease's aetiology. Research has demonstrated that genetic susceptibility to breast cancer is characterised by marked subtype-specific heterogeneity. Rather than conferring a uniform risk, most common susceptibility loci differentially modulate the onset of specific molecular phenotypes (e.g., luminal vs. triple-negative). This suggests that an individual's unique genomic profile does more than just quantify overall oncological risk; it directly shapes the biological identity and dictates the clinical trajectory of the neoplasm 13."